Free Trial

Vinva Investment Management Ltd Raises Stock Position in Colgate-Palmolive Company $CL

Colgate-Palmolive logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Vinva Investment Management increased its Colgate‑Palmolive stake by 27.4% in Q3 to 114,565 shares (worth $9.21M), and other large institutions — including Norges Bank, Schroder, Pacer, Diamond Hill and Acadian — also added significant positions, leaving institutional investors with 80.41% ownership.
  • Colgate beat quarterly expectations (EPS $0.95 vs. $0.91 estimate; revenue $5.23B vs. $5.13B), with revenue up 5.8% year‑over‑year; the stock trades at a ~$75.4B market cap and 35.7 PE, and pays a quarterly dividend of $0.52 (annual yield ~2.2%, payout ratio 79.39%).
  • Insiders sold a total of 184,683 shares worth about $17.49M over the last quarter, with senior executives (e.g., Sally Massey and COO Panagiotis Tsourapas) reducing their holdings by roughly half.
  • MarketBeat previews top five stocks to own in May.

Vinva Investment Management Ltd grew its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 27.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 114,565 shares of the company's stock after buying an additional 24,647 shares during the period. Vinva Investment Management Ltd's holdings in Colgate-Palmolive were worth $9,211,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CL. Norges Bank purchased a new position in Colgate-Palmolive in the second quarter worth approximately $960,390,000. Schroder Investment Management Group lifted its stake in shares of Colgate-Palmolive by 242.3% in the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company's stock valued at $483,962,000 after purchasing an additional 3,768,784 shares during the last quarter. Pacer Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 3,052.2% in the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company's stock valued at $215,602,000 after purchasing an additional 2,611,485 shares during the last quarter. Diamond Hill Capital Management Inc. grew its holdings in shares of Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company's stock worth $645,719,000 after purchasing an additional 2,572,796 shares during the period. Finally, Acadian Asset Management LLC increased its position in shares of Colgate-Palmolive by 42.9% during the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company's stock worth $556,663,000 after purchasing an additional 1,839,853 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $93.55 on Monday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The stock has a market capitalization of $75.41 billion, a PE ratio of 35.71, a PEG ratio of 4.22 and a beta of 0.28. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The stock has a 50-day simple moving average of $88.98 and a 200-day simple moving average of $83.03.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business's quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. On average, analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive's dividend payout ratio is currently 79.39%.

Insider Activity

In related news, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares of the company's stock, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of the firm's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 over the last quarter. Company insiders own 0.41% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CL shares. Bank of America upped their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a "buy" rating in a research report on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research report on Friday, February 13th. TD Cowen reissued a "buy" rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Citigroup increased their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a "buy" rating in a research report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a "hold" rating in a report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $94.75.

Check Out Our Latest Research Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines